DK2167046T3 - Farmaceutisk fast sammensætning omfattende benzazepiner og fremstillingsfremgangsmåder deraf - Google Patents

Farmaceutisk fast sammensætning omfattende benzazepiner og fremstillingsfremgangsmåder deraf

Info

Publication number: DK2167046T3
Authority: DK; Denmark
Prior art keywords: benzazepines; solid composition; preparation processes; pharmaceutical solid; pharmaceutical
Prior art date: 2007-06-21

Application number

DK08777650.6T

Other languages

English (en)

Inventor

Shinsuke Nakagawa

Kai Suzuki

Tadashi Mukai

Original Assignee

Otsuka Pharma Co Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-06-21

Filing date

2008-06-20

Publication date

2011-01-31

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40070798&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK2167046(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2008-06-20 Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd

2011-01-31 Application granted granted Critical

2011-01-31 Publication of DK2167046T3 publication Critical patent/DK2167046T3/da

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
- A61P5/12—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH for decreasing, blocking or antagonising the activity of the posterior pituitary hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin

Landscapes

Health & Medical Sciences (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Diabetes (AREA)
Heart & Thoracic Surgery (AREA)
Hematology (AREA)
Endocrinology (AREA)
Cardiology (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

DK08777650.6T 2007-06-21 2008-06-20 Farmaceutisk fast sammensætning omfattende benzazepiner og fremstillingsfremgangsmåder deraf DK2167046T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
JP2007163551		2007-06-21
PCT/JP2008/061686 WO2008156217A2 (en)	2007-06-21	2008-06-20	Pharmaceutical solid preparation comprising benzazepines and production method thereof

Publications (1)

Publication Number	Publication Date
DK2167046T3 true DK2167046T3 (da)	2011-01-31

Family

ID=40070798

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK08777650.6T DK2167046T3 (da)	2007-06-21	2008-06-20	Farmaceutisk fast sammensætning omfattende benzazepiner og fremstillingsfremgangsmåder deraf

Country Status (24)

Country	Link
US (4)	US10905694B2 (da)
EP (1)	EP2167046B1 (da)
JP (1)	JP5289338B2 (da)
KR (1)	KR101526625B1 (da)
CN (3)	CN101686941A (da)
AR (1)	AR067077A1 (da)
AT (1)	ATE489944T1 (da)
AU (1)	AU2008264445B2 (da)
CA (1)	CA2689467A1 (da)
CY (1)	CY1111939T1 (da)
DE (1)	DE602008003816D1 (da)
DK (1)	DK2167046T3 (da)
ES (1)	ES2354030T3 (da)
HK (1)	HK1201719A1 (da)
HR (1)	HRP20100676T1 (da)
IL (1)	IL202179A (da)
MX (1)	MX2009014193A (da)
MY (1)	MY147599A (da)
PL (1)	PL2167046T3 (da)
PT (1)	PT2167046E (da)
RU (1)	RU2466717C2 (da)
SI (1)	SI2167046T1 (da)
TW (1)	TWI405574B (da)
WO (1)	WO2008156217A2 (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN102293734A (zh) *	2010-06-25	2011-12-28	江苏恒瑞医药股份有限公司	托伐普坦固体分散体及其制备方法
CN102552278A (zh) *	2010-12-23	2012-07-11	天津泰普药品科技发展有限公司	一种提高难溶性药物托伐普坦溶出度的药物组合物
CN102228423B (zh) *	2011-06-29	2013-03-06	重庆市庆余堂制药有限公司	托伐普坦口服固体药物组合物及其制备方法
JP6057628B2 (ja) *	2012-09-06	2017-01-11	クリーンケミカル株式会社	人工透析装置のプライミング方法
TWI660748B (zh)	2013-03-01	2019-06-01	日商大塚製藥股份有限公司	用於口服投藥之包含非晶型托伐普坦（Ｔｏｌｖａｐｔａｎ）的懸浮液
TW201605488A (zh)	2013-10-15	2016-02-16	大塚製藥股份有限公司	用以預防及／或治療多囊腎病之藥物
JP6761695B2 (ja) *	2016-08-16	2020-09-30	信越化学工業株式会社	低置換度ヒドロキシプロピルセルロース及び固形製剤
JP6838446B2 (ja) *	2017-03-22	2021-03-03	ニプロ株式会社	トルバプタン製剤およびその製造方法
JP7352175B2 (ja) *	2019-12-25	2023-09-28	ニプロ株式会社	トルバプタン製剤
CN111888335A (zh) *	2020-08-21	2020-11-06	福安药业集团重庆礼邦药物开发有限公司	一种托伐普坦的药物固体制剂及制备方法
JP2024521354A (ja)	2021-06-02	2024-05-31	エスペリオン・セラピューティクス・インコーポレイテッド	ベンペド酸とトルバブタンを含む組成物及びそれらを用いた治療方法
EP4321154A1 (en)	2022-08-03	2024-02-14	Sanovel Ilac Sanayi Ve Ticaret A.S.	A tablet of tolvaptan and at least one binder processed with spray granulation
CN120115300B (zh) *	2025-05-13	2025-08-05	洛阳栾川钼业集团股份有限公司	滑石抑制剂及其制备方法及从高滑石辉钼矿的泥精矿中回收钼的方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2071511A (en) *	1934-10-01	1937-02-23	Reed & Carnrick	Enteric coating
DE69026708T2 (de)	1989-10-20	1997-04-03	Otsuka Pharma Co Ltd	Benzoheterozyklische verbindungen
TW430561B (en) *	1995-12-20	2001-04-21	Gea Farmaceutisk Fabrik As	Rapid release tablet composition comprising tolfenamic acid or a pharmaceutically acceptable salt thereof as active ingredient and a method of preparing such tablet
JPH09278656A (ja) *	1996-02-05	1997-10-28	Sankyo Co Ltd	経口投与用５α−リダクターゼ阻害製剤及びその製造方法
EP2277517A1 (en) *	1996-11-15	2011-01-26	Ajinomoto Co., Inc.	Nateglinide tablet composition
JP4210355B2 (ja) *	1997-07-03	2009-01-14	大塚製薬株式会社	固形製剤組成物
WO1999059544A2 (en) *	1998-05-18	1999-11-25	Takeda Chemical Industries, Ltd.	Orally disintegrable tablets
EP1054019A1 (en) *	1999-05-18	2000-11-22	Shin-Etsu Chemical Co., Ltd.	Low-substituted hydroxypropyl cellulose
US6946146B2 (en) *	2001-04-18	2005-09-20	Nostrum Pharmaceuticals Inc.	Coating for a sustained release pharmaceutical composition
JP2004026861A (ja) *	2002-06-21	2004-01-29	Shin Etsu Chem Co Ltd	濾過性に優れる水溶性セルロースエーテル及びその選定方法
JP4684545B2 (ja) *	2002-09-26	2011-05-18	大日本住友製薬株式会社	溶出性の良好なイソキサゾール誘導体経口製剤
TWI322689B (en) *	2003-02-24	2010-04-01	Otsuka Pharma Co Ltd	Method for treating severe heart failure and medicament therefor
US20060188563A1 (en) *	2003-03-27	2006-08-24	Hisamitsu Pharmaceutical Co., Inc.	Medicinal oral preparations for colon delivery, medicinal oral preparations for treating colon cancer and medicinal oral preparations for treating colitis
TW200507882A (en)	2003-07-17	2005-03-01	Kyowa Hakko Kogyo Kk	Solid formulations
US8158146B2 (en) *	2005-09-28	2012-04-17	Teva Pharmaceutical Industries Ltd.	Stable combinations of amlodipine besylate and benazepril hydrochloride

2008
- 2008-06-19 TW TW097122847A patent/TWI405574B/zh active
- 2008-06-20 CA CA002689467A patent/CA2689467A1/en not_active Abandoned
- 2008-06-20 CN CN200880021079A patent/CN101686941A/zh active Pending
- 2008-06-20 DE DE602008003816T patent/DE602008003816D1/de active Active
- 2008-06-20 PT PT08777650T patent/PT2167046E/pt unknown
- 2008-06-20 CN CN201410181750.3A patent/CN103989644A/zh active Pending
- 2008-06-20 KR KR1020107001313A patent/KR101526625B1/ko active Active
- 2008-06-20 EP EP08777650A patent/EP2167046B1/en active Active
- 2008-06-20 HR HR20100676T patent/HRP20100676T1/hr unknown
- 2008-06-20 ES ES08777650T patent/ES2354030T3/es active Active
- 2008-06-20 WO PCT/JP2008/061686 patent/WO2008156217A2/en not_active Ceased
- 2008-06-20 AT AT08777650T patent/ATE489944T1/de active
- 2008-06-20 US US12/665,642 patent/US10905694B2/en active Active
- 2008-06-20 AR ARP080102630A patent/AR067077A1/es not_active Application Discontinuation
- 2008-06-20 RU RU2010101797/15A patent/RU2466717C2/ru active
- 2008-06-20 CN CN2013100344832A patent/CN103463095A/zh active Pending
- 2008-06-20 PL PL08777650T patent/PL2167046T3/pl unknown
- 2008-06-20 JP JP2009553855A patent/JP5289338B2/ja active Active
- 2008-06-20 SI SI200830150T patent/SI2167046T1/sl unknown
- 2008-06-20 DK DK08777650.6T patent/DK2167046T3/da active
- 2008-06-20 AU AU2008264445A patent/AU2008264445B2/en active Active
- 2008-06-20 MY MYPI20095067A patent/MY147599A/en unknown
- 2008-06-20 MX MX2009014193A patent/MX2009014193A/es active IP Right Grant
2009
- 2009-11-17 IL IL202179A patent/IL202179A/en active IP Right Grant
2010
- 2010-06-18 HK HK15101484.4A patent/HK1201719A1/xx unknown
2011
- 2011-02-14 CY CY20111100172T patent/CY1111939T1/el unknown
2020
- 2020-11-16 US US17/099,221 patent/US20210069207A1/en not_active Abandoned
- 2020-12-23 US US17/132,852 patent/US20210113582A1/en not_active Abandoned
2023
- 2023-06-16 US US18/336,534 patent/US20230321113A1/en active Pending

Also Published As

Publication number	Publication date
HK1201719A1 (en)	2015-09-11
JP5289338B2 (ja)	2013-09-11
EP2167046A2 (en)	2010-03-31
SI2167046T1 (sl)	2011-03-31
IL202179A (en)	2012-10-31
AR067077A1 (es)	2009-09-30
ATE489944T1 (de)	2010-12-15
TWI405574B (zh)	2013-08-21
EP2167046B1 (en)	2010-12-01
AU2008264445A1 (en)	2008-12-24
CN103463095A (zh)	2013-12-25
DE602008003816D1 (de)	2011-01-13
US20100323006A1 (en)	2010-12-23
BRPI0813100A2 (pt)	2014-12-23
KR101526625B1 (ko)	2015-06-05
TW200911270A (en)	2009-03-16
US10905694B2 (en)	2021-02-02
IL202179A0 (en)	2010-06-16
MX2009014193A (es)	2010-01-28
AU2008264445B2 (en)	2013-06-27
CN103989644A (zh)	2014-08-20
KR20100038386A (ko)	2010-04-14
PT2167046E (pt)	2011-02-10
WO2008156217A3 (en)	2009-02-26
US20210113582A1 (en)	2021-04-22
PL2167046T3 (pl)	2011-05-31
WO2008156217A2 (en)	2008-12-24
JP2010530355A (ja)	2010-09-09
CN101686941A (zh)	2010-03-31
RU2466717C2 (ru)	2012-11-20
HRP20100676T1 (hr)	2011-01-31
RU2010101797A (ru)	2011-07-27
CY1111939T1 (el)	2015-11-04
MY147599A (en)	2012-12-31
ES2354030T3 (es)	2011-03-09
US20230321113A1 (en)	2023-10-12
US20210069207A1 (en)	2021-03-11
CA2689467A1 (en)	2008-12-24

Publication	Publication Date	Title
DK2167046T3 (da)	2011-01-31	Farmaceutisk fast sammensætning omfattende benzazepiner og fremstillingsfremgangsmåder deraf
LTPA2018005I1 (lt)	2018-02-12	Farmacinė kompozicija
DK3345625T3 (da)	2021-02-01	Farmaceutisk sammensætning og indgivelser deraf
BRPI0924137A2 (pt)	2019-09-24	composição farmacêutica sólida compreendendo amlodipina e losartan com melhor estabilidade
BRPI0721651A2 (pt)	2014-04-01	Composição farmacêutica
BRPI0715712A2 (pt)	2014-06-24	Composição farmacêutica
IL242883B (en)	2022-01-01	Aryl-amino and heteroaryl-amino converted deoxazolines and pharmaceutical preparations containing them
BRPI0719393A2 (pt)	2015-03-31	Composição farmacêutica
DK2254873T3 (da)	2014-06-30	Benzodiazepinforbindelse og farmaceutisk sammensætning.
BRPI0820381A2 (pt)	2015-05-19	Formulações farmacêuticas
DK1884242T3 (da)	2013-05-06	Farmaceutisk sammensætning omfattende lurasidon
DK2120884T3 (da)	2011-02-07	Farmaceutisk sammensætning
DK2154966T3 (da)	2013-11-18	Benzimidazoler og farmaceutiske sammensætninger deraf
BRPI0716445A2 (pt)	2013-09-17	composiÇço farmacÊutica
BRPI0720234A2 (pt)	2013-12-24	Composição farmacêutica
IL204706A0 (en)	2010-11-30	Matrix - type pharmaceutical solid preparation
DK2475649T3 (da)	2014-11-03	Indenonderivat og farmaceutisk sammensætning omfattende samme
PT2209464E (pt)	2014-09-05	Composição farmacêutica antimalárica
DK2182988T3 (da)	2014-05-26	Radiofarmaceutisk præparat
DK2152699T3 (da)	2011-04-18	Quinolon-forbindelse og farmaceutisk sammensætning
DK2029561T3 (da)	2014-11-10	Tricyclisk forbindelse og farmaceutisk anvendelse deraf
BRPI0912074A2 (pt)	2018-10-02	composto e composição farmacêutica
EP2156832A4 (en)	2010-11-24	PHARMACEUTICAL COMPOSITION
DK2236145T3 (da)	2014-08-04	Farmaceutisk sammensætning og kombineret middel
BRPI0810057A2 (pt)	2014-10-21	Composição farmacêutica contendo floroglucinol e paracetamol